FDA pulls pre-term birth drug Makena and its generics from market after 12 years

The U.S. Food and Drug Administration said Thursday it has reached a final decision to fully withdraw approval of pre-term birth drug Makena and its generics, a full 12 years after it hit the market. The drug was approved using the agency’s accelerate approval pathway in 2011 as a way to reduce the risk of pre-term birth in women pregnant with one baby who had a history of spontaneous pre-term birth.

The drug was approved using the agency’s accelerate approval pathway in 2011 as a way to reduce the risk of pre-term birth in women pregnant with one baby who had a history of spontaneous pre-term birth.

I smell some up coming big big pharma litigation.

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

FDA forces unproven premature birth drug Makena off marketThe Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market
ソース: WOKVNews - 🏆 247. / 63 続きを読む »

FDA forces unproven premature birth drug Makena off marketThe Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market.
ソース: ksatnews - 🏆 442. / 53 続きを読む »

FDA forces unproven premature birth drug Makena off marketThe Food and Drug Administration on Thursday ordered the immediate market withdrawal of a drug intended to prevent premature births, which has remained available for years despite data showing it doesn’t help pregnant women.
ソース: WashTimes - 🏆 235. / 63 続きを読む »